Literature DB >> 17435970

Biodegradable poly(2-dimethylamino ethylamino)phosphazene for in vivo gene delivery to tumor cells. Effect of polymer molecular weight.

Holger K de Wolf1, Markus de Raad, Cor Snel, Mies J van Steenbergen, Marcel H A M Fens, Gert Storm, Wim E Hennink.   

Abstract

PURPOSE: Previously, we have shown that complexes of plasmid DNA with the biodegradable polymer poly(2-dimethylamino ethylamino)phosphazene (p(DMAEA)-ppz) mediated tumor selective gene expression after intravenous administration in mice. In this study, we investigated the effect of p(DMAEA)-ppz molecular weight on both in vitro and in vivo tumor transfection, as well as on complex induced toxicity.
MATERIALS AND METHODS: p(DMAEA)-ppz with a broad molar mass distribution was fractionated by preparative size exclusion chromatography. Polyplexes consisting of plasmid DNA and the collected polymer fractions were tested for biophysical properties, (cyto)toxicity and transfection activity.
RESULTS: Four p(DMAEA)-ppz fractions were collected with weight average molecular weights ranging from 130 to 950 kDa, and with narrow molecular mass distributions (Mw/Mn from 1.1 to 1.3). At polymer-to-DNA (N/P) ratios above 6, polyplexes based on these polymers were all positively charged (zeta potential 25-29 mV), and had a size of 80-90 nm. The in vitro cytotoxicity of the polyplexes positively correlated with polymer molecular weight. The in vitro transfection activity of the different polyplexes depended on their N/P ratio, and was affected by the degree of cytotoxicity, as well as the colloidal stability of the different polyplexes. Intravenous administration of polyplexes based on the high molecular weight polymers led to apparent toxicity, as a result of polyplex-induced erythrocyte aggregation. On the other hand, administration of polyplexes based on low molecular weight p(DMAEA)-ppz's (Mw 130 kDa) did not show signs of toxicity and resulted in tumor selective gene expression.
CONCLUSION: Polymer molecular weight fractionation enabled us to optimize the transfection efficiency/toxicity ratio of p(DMAEA)-ppz polyplexes for in vitro and in vivo tumor transfection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435970      PMCID: PMC1915646          DOI: 10.1007/s11095-007-9299-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

1.  Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery.

Authors:  D V Schaffer; N A Fidelman; N Dan; D A Lauffenburger
Journal:  Biotechnol Bioeng       Date:  2000-03-05       Impact factor: 4.530

Review 2.  Polymers in drug delivery.

Authors:  O Pillai; R Panchagnula
Journal:  Curr Opin Chem Biol       Date:  2001-08       Impact factor: 8.822

3.  Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application.

Authors:  R Kircheis; L Wightman; A Schreiber; B Robitza; V Rössler; M Kursa; E Wagner
Journal:  Gene Ther       Date:  2001-01       Impact factor: 5.250

Review 4.  Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives.

Authors:  Michael Neu; Dagmar Fischer; Thomas Kissel
Journal:  J Gene Med       Date:  2005-08       Impact factor: 4.565

5.  Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy.

Authors:  C M Ward; M L Read; L W Seymour
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

6.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo.

Authors:  L Wightman; R Kircheis; V Rössler; S Carotta; R Ruzicka; M Kursa; E Wagner
Journal:  J Gene Med       Date:  2001 Jul-Aug       Impact factor: 4.565

Review 7.  Non-viral vectors in cancer gene therapy: principles and progress.

Authors:  A G Schatzlein
Journal:  Anticancer Drugs       Date:  2001-04       Impact factor: 2.248

Review 8.  Targeting tumors with non-viral gene delivery systems.

Authors:  Manfred Ogris; Ernst Wagner
Journal:  Drug Discov Today       Date:  2002-04-15       Impact factor: 7.851

9.  Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery.

Authors:  Marjo Männistö; Sylvie Vanderkerken; Veska Toncheva; Matti Elomaa; Marika Ruponen; Etienne Schacht; Arto Urtti
Journal:  J Control Release       Date:  2002-09-18       Impact factor: 9.776

10.  Biocompatibility of polycations: in vitro agglutination and lysis of red blood cells and in vivo toxicity.

Authors:  Elisabeth Moreau; Martine Domurado; Pascal Chapon; Michel Vert; Dominique Domurad
Journal:  J Drug Target       Date:  2002-03       Impact factor: 5.121

View more
  10 in total

1.  Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine.

Authors:  Shanta Raj Bhattarai; Elayaraja Muthuswamy; Amit Wani; Michal Brichacek; Antonio L Castañeda; Stephanie L Brock; David Oupicky
Journal:  Pharm Res       Date:  2010-08-21       Impact factor: 4.200

Review 2.  Lipid-based vectors for siRNA delivery.

Authors:  Shubiao Zhang; Defu Zhi; Leaf Huang
Journal:  J Drug Target       Date:  2012-09-20       Impact factor: 5.121

3.  Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release.

Authors:  David S H Chu; Russell N Johnson; Suzie H Pun
Journal:  J Control Release       Date:  2011-10-20       Impact factor: 9.776

4.  The effect of N/P ratio on the in vitro and in vivo interaction properties of PEGylated poly[2-(dimethylamino)ethyl methacrylate]-based siRNA complexes.

Authors:  Dana J Gary; Jungbin Min; Youngwook Kim; Keunchil Park; You-Yeon Won
Journal:  Macromol Biosci       Date:  2013-07-05       Impact factor: 4.979

5.  Membrane and nuclear permeabilization by polymeric pDNA vehicles: efficient method for gene delivery or mechanism of cytotoxicity?

Authors:  Giovanna Grandinetti; Adam E Smith; Theresa M Reineke
Journal:  Mol Pharm       Date:  2012-02-01       Impact factor: 4.939

6.  Reducible HPMA-co-oligolysine copolymers for nucleic acid delivery.

Authors:  Julie Shi; Russell N Johnson; Joan G Schellinger; Peter M Carlson; Suzie H Pun
Journal:  Int J Pharm       Date:  2011-08-27       Impact factor: 5.875

7.  Polyphosphazenes: Multifunctional, Biodegradable Vehicles for Drug and Gene Delivery.

Authors:  Ian Teasdale; Oliver Brüggemann
Journal:  Polymers (Basel)       Date:  2013-03-01       Impact factor: 4.329

8.  Engineering biodegradable and multifunctional peptide-based polymers for gene delivery.

Authors:  Julie Shi; Joan G Schellinger; Suzie H Pun
Journal:  J Biol Eng       Date:  2013-10-24       Impact factor: 4.355

9.  Increased RNAi Efficacy in Spodoptera exigua via the Formulation of dsRNA With Guanylated Polymers.

Authors:  Olivier Christiaens; Myriam G Tardajos; Zarel L Martinez Reyna; Mamoni Dash; Peter Dubruel; Guy Smagghe
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

Review 10.  Main-Chain Phosphorus-Containing Polymers for Therapeutic Applications.

Authors:  Paul Strasser; Ian Teasdale
Journal:  Molecules       Date:  2020-04-08       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.